Sanofi-Aventis CEO Chris Viehbacher said Wednesday that he believes his French pharmaceutical company will eventually buy U.S. biotech company Genzyme at a reasonable price. However, he expects it will take some time to agree o…
Health care costs will increase between 10.5% and 11% over the next year, marginally higher than last year’s rise, consulting firm Aon said Wednesday. Aon pins the increase on factors such as rising prescription drug costs and …
Zimmer Holdings is gaining fresh interest due to favorable prospects in the business in which it has a 25% market share, a stock that’s been depressed and an industry that’s consolidating. Plus, Zimmer is viewed as buyout prey …
A new television advertisement is suggesting that McDonald’s food is so bad for people’s health that it can lead to premature death. The ad, paid for by the Physicians Committee for Responsible Medicine, will begin to air in th…
Can shareholder’s of a company sue its auditor for failing to catch or report fraud? We’ll know Tuesday after the New York Court of Appeals rules on the legal doctrine of “in pari delicto” — in equal fault.
Co…